Q-Switched Nd:YAG in Macular Amyloidosis

Macular Amyloidosis Clinical Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

Clinical Trial Description

We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Amyloidosis
• Macular Amyloidosis

• NCT number: NCT00353392
• Study type: Interventional
• Source: hahid Beheshti University of Medical Sciences
• Status: Completed
• Phase: Phase 1
• Start date: March 2006
• Completion date: August 2006